Erythropoietin promoted the proliferation of hepatocellular carcinoma through hypoxia induced translocation of its specific receptor

Abstract Background Erythropoietin (EPO) is a hypoxia-inducible stimulator of erythropoiesis. Besides its traditional application in anemia therapy, it offers an effective treatment in the cancer patients, especially those who receive chemotherapy. Several reports indicated that it could promote the...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Shuo Miao, Su-Mei Wang, Xue Cheng, Yao-Feng Li, Qing-Song Zhang, Gang Li, Song-Qing He, Xiao-Ping Chen, Ping Wu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2017-12-01
Colecção:	Cancer Cell International
Assuntos:	Erythropoietin Erythropoietin receptor Hepatocellular carcinoma Hypoxia Proliferation
Acesso em linha:	http://link.springer.com/article/10.1186/s12935-017-0494-7
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!